SELLAS Life Sciences Group, Inc.
SLS
$1.41
$0.010.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 20.69% | 21.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.40% | -3.83% | |||
| Operating Income | -9.40% | 3.83% | |||
| Income Before Tax | 5.22% | 4.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.22% | 4.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.22% | 4.85% | |||
| EBIT | -9.40% | 3.83% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 12.49% | 19.68% | |||
| Normalized Basic EPS | -1.69% | 19.63% | |||
| EPS Diluted | 12.49% | 19.92% | |||
| Normalized Diluted EPS | -1.69% | 19.63% | |||
| Average Basic Shares Outstanding | 8.40% | 18.43% | |||
| Average Diluted Shares Outstanding | 8.40% | 18.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||